MedPath

The effect of Levothyroxine on the infant development status in pregnant women with autoimmune non overt thyroid disease

Not Applicable
Recruiting
Conditions
Thyroid disorders.
Disorder of thyroid, unspecified
Registration Number
IRCT2017090414849N6
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
1600
Inclusion Criteria

pregnant women during the first 20 weeks of pregnancy.
Exclusion criteria: multiple pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Communication developmental status. Timepoint: Since 4 months after birth. Method of measurement: Ages and Stages Questionnaire (ASQ).;Gross motor developmental status. Timepoint: Since 4 months after birth. Method of measurement: Ages and Stages Questionnaire (ASQ).;Fine motor developmental status. Timepoint: Since 4 months after birth. Method of measurement: Ages and Stages Questionnaire (ASQ).;Problem solving developmental status. Timepoint: Since 4 months after birth. Method of measurement: Ages and Stages Questionnaire (ASQ).;Personal, social developmental status. Timepoint: Since 4 months after birth. Method of measurement: Ages and Stages Questionnaire (ASQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath